BDNF and early-onset autosomal dominant Alzheimer disease: On the other hand, pretreatment with BDNF prevented MAPK phosphorylation activated by amyloid-beta peptide in the entorhinal cortex of Alzheimer’s disease, suggesting a negative correlation of BDNF with MAPK signaling [23].